Clinical Trials Directory

Trials / Completed

CompletedNCT03789396

Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients

Status
Completed
Phase
Study type
Observational
Enrollment
572 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 109 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.

Detailed description

Supplemental oxygen is fundamental in caring for critically ill trauma. While the avoidance of hypoxia is vital, the current clinical practice of excessive oxygenation settings is common, and unnecessary, and may even be harmful. An expert panel convened to define optimal oxygenation targets in critically ill trauma patients. The strong consensus was to target normoxia at an oxygen saturation (SpO2) range of 90-96% and arterial oxygen (PaO2) range of 60-100 mmHg. Accordingly, a pilot trial implementation of this consensus will occur for the care of trauma patients. Specific Aim: This is an observational pre/post study to evaluate the impact of targeted normoxia implementation in optimizing oxygen delivery and oxygenation in critically ill trauma patients. Hypotheses: That the clinical efforts to improve adherence to oxygen guidelines will: 1. improve the proportion of time spent with target normoxia thresholds (oxygen saturation SpO2 90-96%) by 2. reducing utilization of unnecessary supplementation oxygen 3. without a substantive increase in hypoxic episodes or an adverse impact on clinical outcomes.

Conditions

Interventions

TypeNameDescription
OTHERTargeted Normoxia (oxygen saturation 90-96%)The intervention (post-implementation) group will be trauma patients admitted to the ICU during the 6 months after the targeted normoxia implementation
OTHERUsual Care OxygenationThe control (pre-implementation) group will be trauma patients admitted to the ICU during the 12 months prior to the targeted normoxia implementation

Timeline

Start date
2018-01-01
Primary completion
2019-09-19
Completion
2022-10-01
First posted
2018-12-28
Last updated
2024-02-15
Results posted
2024-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03789396. Inclusion in this directory is not an endorsement.